Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Davé V[au]:

PTEN proteoforms in biology and disease. Malaney P et al. Cell Mol Life Sci. (2017)

Reply. Dave VP et al. Retina. (2017)

PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer. Malaney P et al. Cell Cycle. (2018)

Search results

Items: 1 to 50 of 295

1.

Orbital Exenteration in Rhino-Orbito-Cerebral Mucormycosis: A Prospective Analytical Study with Scoring System.

Shah K, Dave V, Bradoo R, Shinde C, Prathibha M.

Indian J Otolaryngol Head Neck Surg. 2019 Jun;71(2):259-265. doi: 10.1007/s12070-018-1293-8. Epub 2018 Mar 13.

PMID:
31275841
2.

Clinical presentations and comparative outcomes of primary versus deferred intraocular lens explantation in delayed-onset endophthalmitis.

Dave VP, Pathengay A, Sharma S, Govindhari V, Karolia R, Pappuru RR, Das T.

Indian J Ophthalmol. 2019 Jul;67(7):1101-1104. doi: 10.4103/ijo.IJO_1494_18.

3.

Analyzing aggregation propensities of clinically relevant PTEN mutants: a new culprit in pathogenesis of cancer and other PTENopathies.

Palumbo E, Zhao B, Xue B, Uversky VN, Davé V.

J Biomol Struct Dyn. 2019 Jun 22:1-14. doi: 10.1080/07391102.2019.1630005. [Epub ahead of print]

PMID:
31232187
4.
5.

A facile one pot synthesis of novel pyrimidine derivatives of 1,5-benzodiazepines via domino reaction and their antibacterial evaluation.

Misra A, Jain S, Kishore D, Dave V, Reddy KR, Sadhu V, Dwivedi J, Sharma S.

J Microbiol Methods. 2019 Aug;163:105648. doi: 10.1016/j.mimet.2019.105648. Epub 2019 Jun 10.

PMID:
31195033
6.

Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model.

Paliwal S, Tilak A, Sharma J, Dave V, Sharma S, Yadav R, Patel S, Verma K, Tak K.

Lipids Health Dis. 2019 Jun 7;18(1):133. doi: 10.1186/s12944-019-1064-x.

7.

OCT angiography fractal analysis-based quantification of macular vascular density in branch retinal vein occlusion eyes.

Dave VP, Pappuru RR, Gindra R, Ananthakrishnan A, Modi S, Trivedi M, Harikumar P.

Can J Ophthalmol. 2019 Jun;54(3):297-300. doi: 10.1016/j.jcjo.2018.06.009. Epub 2018 Aug 30.

PMID:
31109467
8.

Infectious endophthalmitis leading to evisceration: spectrum of bacterial and fungal pathogens and antibacterial susceptibility profile.

Dave TV, Dave VP, Sharma S, Karolia R, Joseph J, Pathengay A, Pappuru RR, Das T.

J Ophthalmic Inflamm Infect. 2019 May 16;9(1):9. doi: 10.1186/s12348-019-0174-y.

9.

PEG-PLGA- hybrid nanoparticles loaded with etoricoxib - phospholipid complex for effective treatment of inflammation in rat model.

Dave V, Srivastava P, Tak K, Sharma S.

J Microencapsul. 2019 May;36(3):236-249. doi: 10.1080/02652048.2019.1617362. Epub 2019 Jun 19.

PMID:
31092089
10.

Critical Role for TCR Signal Strength and MHC Specificity in ThPOK-Induced CD4 Helper Lineage Choice.

Zeidan N, Damen H, Roy DC, Dave VP.

J Immunol. 2019 Jun 1;202(11):3211-3225. doi: 10.4049/jimmunol.1801464. Epub 2019 Apr 29.

PMID:
31036767
11.

Impacted Incus Foreign Body in the Eustachian Tube.

Parelkar K, Shere D, Wallic A, Dave V, Rao K.

Iran J Otorhinolaryngol. 2019 Mar;31(103):123-126.

12.

Flurbiprofen-loaded ethanolic liposome particles for biomedical applications.

Paliwal S, Tilak A, Sharma J, Dave V, Sharma S, Verma K, Tak K, Reddy KR, Sadhu V.

J Microbiol Methods. 2019 Jun;161:18-27. doi: 10.1016/j.mimet.2019.04.001. Epub 2019 Apr 3.

PMID:
30951793
13.

Correlation of Eustachian Tube Dysfunction with Results of Tympanoplasty in Mucosal Type of Chronic Suppurative Otitis Media.

Dave V, Ruparel M.

Indian J Otolaryngol Head Neck Surg. 2019 Mar;71(1):10-13. doi: 10.1007/s12070-018-1525-y. Epub 2018 Nov 2.

PMID:
30906705
14.

Lipid-polymer hybrid nanoparticles: Synthesis strategies and biomedical applications.

Dave V, Tak K, Sohgaura A, Gupta A, Sadhu V, Reddy KR.

J Microbiol Methods. 2019 May;160:130-142. doi: 10.1016/j.mimet.2019.03.017. Epub 2019 Mar 18. Review.

PMID:
30898602
15.

Endophthalmitis following Suture Removal - Clinical Outcomes and Microbiological Profile.

Panchal B, Tyagi M, Pathengay A, Sharma S, Dave VP, Gandhi U, Balakrishnan D, Pappuru RR, Joseph J, Kekunnaya R, Das T.

Semin Ophthalmol. 2019;34(2):115-123. doi: 10.1080/08820538.2019.1590605. Epub 2019 Mar 16.

PMID:
30879381
16.

Green synthesis and characterization of copper nanoparticles by Tinospora cardifolia to produce nature-friendly copper nano-coated fabric and their antimicrobial evaluation.

Sharma P, Pant S, Dave V, Tak K, Sadhu V, Reddy KR.

J Microbiol Methods. 2019 May;160:107-116. doi: 10.1016/j.mimet.2019.03.007. Epub 2019 Mar 11.

PMID:
30871999
17.

Trends in microbiological spectrum of endophthalmitis at a single tertiary care ophthalmic hospital in India: a review of 25 years.

Joseph J, Sontam B, Guda SJM, Gandhi J, Sharma S, Tyagi M, Dave VP, Das T.

Eye (Lond). 2019 Jul;33(7):1090-1095. doi: 10.1038/s41433-019-0380-8. Epub 2019 Feb 21.

PMID:
30792523
18.

Endoscopic vitrectomy in endophthalmitis: initial experience of 33 cases at a tertiary eye care center.

Dave VP, Pappuru RR, Tyagi M, Pathengay A, Das T.

Clin Ophthalmol. 2019 Feb 5;13:243-251. doi: 10.2147/OPTH.S185716. eCollection 2019.

19.

Peripapillary Versus Macular Combined Hamartoma of the Retina and Retinal Pigment Epithelium: Imaging Characteristics.

Gupta R, Fung AT, Lupidi M, Pappuru RR, Nayak S, Sahoo NK, Kaliki S, Yannuzzi L, Reid K, Lim L, Sacconi R, Dave V, Singh SR, Ayachit A, Gabrielle PH, Cai S, Lima LH, Querques G, Arevalo JF, Freund KB, Shields CL, Chhablani J.

Am J Ophthalmol. 2019 Apr;200:263-269. doi: 10.1016/j.ajo.2019.01.016. Epub 2019 Jan 26.

PMID:
30689986
20.

ENTEROCOCCUS ENDOPHTHALMITIS: Clinical Settings, Antimicrobial Susceptibility, and Management Outcomes.

Dave VP, Pathengay A, Braimah IZ, Panchal B, Sharma S, Pappuru RR, Mathai A, Tyagi M, Narayanan R, Jalali S, Das T.

Retina. 2019 Jan 23. doi: 10.1097/IAE.0000000000002462. [Epub ahead of print]

PMID:
30681640
21.

When color matters: Waardenburg syndrome.

Dave TV, Pappuru RR, Dave VP.

Indian J Ophthalmol. 2019 Jan;67(1):135. doi: 10.4103/ijo.IJO_889_18. No abstract available.

22.

Reply.

Dave VP, Pathengay A, Sharma S, Naveen N, Basu S, Pappuru RR, Das T.

Am J Ophthalmol. 2019 Mar;199:258. doi: 10.1016/j.ajo.2018.10.024. Epub 2018 Dec 15. No abstract available.

PMID:
30563613
23.

MicroRNA amplification and detection technologies: opportunities and challenges for point of care diagnostics.

Dave VP, Ngo TA, Pernestig AK, Tilevik D, Kant K, Nguyen T, Wolff A, Bang DD.

Lab Invest. 2019 Apr;99(4):452-469. doi: 10.1038/s41374-018-0143-3. Epub 2018 Dec 12. Review.

PMID:
30542067
24.

Vitrectomy with Silicone Oil Tamponade in Rhegmatogenous Retinal Detachment following Acute Retinal Necrosis: Clinical Outcomes and Prognostic Factors.

Dave VP, Pappuru RR, Pathengay A, Tyagi M, Narayanan R, Jalali S.

Semin Ophthalmol. 2018 Nov 29:1-5. doi: 10.1080/08820538.2018.1551907. [Epub ahead of print]

PMID:
30496028
25.

Clinical presentations, management outcomes, and diagnostic dilemma in Kocuria endophthalmitis.

Dave VP, Joseph J, Pathengay A, Pappuru RR.

J Ophthalmic Inflamm Infect. 2018 Nov 20;8(1):21. doi: 10.1186/s12348-018-0163-6.

26.

Choroidal neovascularization associated with combined hamartoma of retina and retinal pigment epithelium: Multimodal imaging.

Gupta R, Pappuru RR, Dave VP, Chhablani J.

Indian J Ophthalmol. 2018 Dec;66(12):1866-1868. doi: 10.4103/ijo.IJO_992_18.

27.

Factors associated with immunotherapy selection in patients with advanced melanoma.

Joseph RW, Shillington AC, Macahilig C, Diede SJ, Dave V, Harshaw Q, Liu FX.

Immunotherapy. 2018 Nov;10(16):1361-1369. doi: 10.2217/imt-2018-0150. Epub 2018 Nov 8.

28.

Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.

Zhao F, Dave VS, Mar MZ, Perri JR.

Int J Pharm Compd. 2018 Sep-Oct;22(5):433-439.

PMID:
30384342
29.

Early detection of capping risk in pharmaceutical compacts.

Xu X, Vallabh CKP, Hoag SW, Dave VS, Cetinkaya C.

Int J Pharm. 2018 Dec 20;553(1-2):338-348. doi: 10.1016/j.ijpharm.2018.10.052. Epub 2018 Oct 24.

PMID:
30367987
30.

A Critique of Computer Simulation Software's Used in Pharmacokinetics and Pharmacodynamics Analysis.

Dave V, Yadav RB, Yadav S, Sharma S, Sahu RK, Ajayi AF.

Curr Clin Pharmacol. 2018;13(4):216-235. doi: 10.2174/1574884713666181025144845.

PMID:
30360723
31.

CLINICAL PRESENTATIONS, DIAGNOSIS, AND MANAGEMENT OUTCOMES OF CURVULARIA ENDOPHTHALMITIS AND A REVIEW OF LITERATURE.

Dave VP, Joseph J, Pathengay A, Pappuru RR, Das T.

Retina. 2018 Oct 23. doi: 10.1097/IAE.0000000000002375. [Epub ahead of print]

PMID:
30358762
32.

Rapid detection of Salmonella enterica in food samples by a novel approach with combination of sample concentration and direct PCR.

Vinayaka AC, Ngo TA, Kant K, Engelsmann P, Dave VP, Shahbazi MA, Wolff A, Bang DD.

Biosens Bioelectron. 2019 Mar 15;129:224-230. doi: 10.1016/j.bios.2018.09.078. Epub 2018 Sep 26.

PMID:
30318404
33.

Filamentous gram-negative bacteria masquerading as actinomycetes in infectious endophthalmitis: a review of three cases.

Joseph J, Sharma S, Dave VP.

J Ophthalmic Inflamm Infect. 2018 Oct 11;8(1):15. doi: 10.1186/s12348-018-0157-4.

34.

Diagnosis, Clinical Presentations, and Outcomes of Nocardia Endophthalmitis.

Dave VP, Pathengay A, Sharma S, Naveen N, Basu S, Pappuru RR, Das T.

Am J Ophthalmol. 2019 Jan;197:53-58. doi: 10.1016/j.ajo.2018.09.007. Epub 2018 Sep 19.

PMID:
30240723
35.

Influence of punch geometry (head-flat diameter) and tooling type ('B' or 'D') on the physical-mechanical properties of formulation tablets.

Shah HG, Dugar RP, Li H, Dave VS, Dave RH.

Drug Dev Ind Pharm. 2019 Jan;45(1):117-123. doi: 10.1080/03639045.2018.1525395. Epub 2018 Oct 24.

PMID:
30231647
36.

Cyst Excision and Globe Preservation in a Case of Microphthalmos With a Large Orbital Cyst and Visual Potential.

Dave TV, Cicinelli MV, Dave VP, Pappuru RR, Naik MN, Mishra DK.

Ophthalmic Plast Reconstr Surg. 2018 Sep/Oct;34(5):e170-e172. doi: 10.1097/IOP.0000000000001200.

PMID:
30198983
37.

Physical properties and solubility studies of Nifedipine-PEG 1450/HPMCAS-HF solid dispersions.

Haware RV, Vinjamuri BP, Gavireddi M, Dave VS, Gupta D, Chougule MB, Stagner WC.

Pharm Dev Technol. 2019 Jun;24(5):550-559. doi: 10.1080/10837450.2018.1519573. Epub 2018 Dec 5.

PMID:
30175691
38.

Concept and Uptake of Just-A-Minute Clinical Pearl: A Novel Tele-Ophthalmology Teaching Tool.

Dave VP, Pathengay A, Keeffe J, Green C.

Asia Pac J Ophthalmol (Phila). 2018 Nov-Dec;7(6):442-445. doi: 10.22608/APO.2018107. Epub 2018 Jul 25.

PMID:
30044062
39.

CLINICAL PRESENTATIONS, DIAGNOSTIC DILEMMA, AND MANAGEMENT OUTCOMES OF CHRONIC POSTOPERATIVE ENDOPHTHALMITIS CAUSED BY STEPHANOASCUS CIFERRII.

Dave VP, Sharma S, Dave PJ, Joseph J, Pappuru RR.

Retin Cases Brief Rep. 2018 Jul 17. doi: 10.1097/ICB.0000000000000782. [Epub ahead of print]

PMID:
30028787
40.

Salts of Therapeutic Agents: Chemical, Physicochemical, and Biological Considerations.

Gupta D, Bhatia D, Dave V, Sutariya V, Varghese Gupta S.

Molecules. 2018 Jul 14;23(7). pii: E1719. doi: 10.3390/molecules23071719. Review.

41.

Lipid-polymer hybrid nanoparticles: Development & statistical optimization of norfloxacin for topical drug delivery system.

Dave V, Yadav RB, Kushwaha K, Yadav S, Sharma S, Agrawal U.

Bioact Mater. 2017 Jul 17;2(4):269-280. doi: 10.1016/j.bioactmat.2017.07.002. eCollection 2017 Dec.

42.

Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9/Cpf1 ribonucleoproteins in hard-to-modify cells.

Del'Guidice T, Lepetit-Stoffaes JP, Bordeleau LJ, Roberge J, Théberge V, Lauvaux C, Barbeau X, Trottier J, Dave V, Roy DC, Gaillet B, Garnier A, Guay D.

PLoS One. 2018 Apr 4;13(4):e0195558. doi: 10.1371/journal.pone.0195558. eCollection 2018.

43.

Correlation of solid dosage porosity and tensile strength with acoustically extracted mechanical properties.

Xu X, Mack C, Cleland ZJ, Vallabh CKP, Dave VS, Cetinkaya C.

Int J Pharm. 2018 May 5;542(1-2):153-163. doi: 10.1016/j.ijpharm.2018.03.018. Epub 2018 Mar 10.

PMID:
29535040
44.

Microfluidic devices for sample preparation and rapid detection of foodborne pathogens.

Kant K, Shahbazi MA, Dave VP, Ngo TA, Chidambara VA, Than LQ, Bang DD, Wolff A.

Biotechnol Adv. 2018 Jul - Aug;36(4):1003-1024. doi: 10.1016/j.biotechadv.2018.03.002. Epub 2018 Mar 10. Review.

PMID:
29534915
45.

Bridging gaps in care: Implementation of a pharmacist-led transitions-of-care program.

Brantley AF, Rossi DM, Barnes-Warren S, Francisco JC, Schatten I, Dave V.

Am J Health Syst Pharm. 2018 Mar 1;75(5 Supplement 1):S1-S5. doi: 10.2146/ajhp160652.

PMID:
29472274
46.

In Vitro Evaluation of Eslicarbazepine Delivery via Enteral Feeding Tubes.

Reindel K, Zhao F, Hughes S, Dave VS.

Hosp Pharm. 2017 Dec;52(11):752-760. doi: 10.1177/0018578717732340. Epub 2017 Sep 25.

47.

Endophthalmitis Progressing to Panophthalmitis: Clinical Features, Demographic Profile, and Factors Predicting Outcome.

Pappuru RR, Dave VP, Pathengay A, Gangakhedkar S, Sharma S, Narayanan R, Tyagi M, Grzybowski A, Das T.

Semin Ophthalmol. 2018;33(5):671-674. doi: 10.1080/08820538.2017.1416411. Epub 2017 Dec 19.

PMID:
29256717
48.

Patient-Reported Outcomes and Opioid Use by Outpatient Cancer Patients.

Moryl N, Dave V, Glare P, Bokhari A, Malhotra VT, Gulati A, Hung J, Puttanniah V, Griffo Y, Tickoo R, Wiesenthal A, Horn SD, Inturrisi CE.

J Pain. 2018 Mar;19(3):278-290. doi: 10.1016/j.jpain.2017.11.001. Epub 2017 Nov 14.

49.

PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.

Malaney P, Palumbo E, Semidey-Hurtado J, Hardee J, Stanford K, Kathiriya JJ, Patel D, Tian Z, Allen-Gipson D, Davé V.

Cell Cycle. 2018;17(8):947-962. doi: 10.1080/15384101.2017.1388970. Epub 2018 May 31.

50.

Reply.

Dave VP, Pathengay A, Budhiraja I, Pappuru RR.

Retina. 2017 Nov;37(11):e145. doi: 10.1097/IAE.0000000000001900. No abstract available.

PMID:
29065082

Supplemental Content

Support Center